Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 308

1.

Characterization of RyDEN (C19orf66) as an Interferon-Stimulated Cellular Inhibitor against Dengue Virus Replication.

Suzuki Y, Chin WX, Han Q, Ichiyama K, Lee CH, Eyo ZW, Ebina H, Takahashi H, Takahashi C, Tan BH, Hishiki T, Ohba K, Matsuyama T, Koyanagi Y, Tan YJ, Sawasaki T, Chu JJ, Vasudevan SG, Sano K, Yamamoto N.

PLoS Pathog. 2016 Jan 6;12(1):e1005357. doi: 10.1371/journal.ppat.1005357. eCollection 2016 Jan.

2.

Protein kinase regulated by dsRNA downregulates the interferon production in dengue virus- and dsRNA-stimulated human lung epithelial cells.

Li Y, Xie J, Wu S, Xia J, Zhang P, Liu C, Zhang P, Huang X.

PLoS One. 2013;8(1):e55108. doi: 10.1371/journal.pone.0055108. Epub 2013 Jan 25.

3.

Inhibition of dengue and chikungunya virus infections by RIG-I-mediated type I interferon-independent stimulation of the innate antiviral response.

Olagnier D, Scholte FE, Chiang C, Albulescu IC, Nichols C, He Z, Lin R, Snijder EJ, van Hemert MJ, Hiscott J.

J Virol. 2014 Apr;88(8):4180-94. doi: 10.1128/JVI.03114-13. Epub 2014 Jan 29.

4.

Role of human heterogeneous nuclear ribonucleoprotein C1/C2 in dengue virus replication.

Dechtawewat T, Songprakhon P, Limjindaporn T, Puttikhunt C, Kasinrerk W, Saitornuang S, Yenchitsomanus PT, Noisakran S.

Virol J. 2015 Feb 6;12:14. doi: 10.1186/s12985-014-0219-7.

5.

IRAV (FLJ11286), an Interferon-Stimulated Gene with Antiviral Activity against Dengue Virus, Interacts with MOV10.

Balinsky CA, Schmeisser H, Wells AI, Ganesan S, Jin T, Singh K, Zoon KC.

J Virol. 2017 Feb 14;91(5). pii: e01606-16. doi: 10.1128/JVI.01606-16. Print 2017 Mar 1.

6.

Live Cell Analysis and Mathematical Modeling Identify Determinants of Attenuation of Dengue Virus 2'-O-Methylation Mutant.

Schmid B, Rinas M, Ruggieri A, Acosta EG, Bartenschlager M, Reuter A, Fischl W, Harder N, Bergeest JP, Flossdorf M, Rohr K, Höfer T, Bartenschlager R.

PLoS Pathog. 2015 Dec 31;11(12):e1005345. doi: 10.1371/journal.ppat.1005345. eCollection 2015 Dec.

7.

Dengue Virus Selectively Annexes Endoplasmic Reticulum-Associated Translation Machinery as a Strategy for Co-opting Host Cell Protein Synthesis.

Reid DW, Campos RK, Child JR, Zheng T, Chan KWK, Bradrick SS, Vasudevan SG, Garcia-Blanco MA, Nicchitta CV.

J Virol. 2018 Mar 14;92(7). pii: e01766-17. doi: 10.1128/JVI.01766-17. Print 2018 Apr 1.

8.

Cellular microRNA-miR-548g-3p modulates the replication of dengue virus.

Wen W, He Z, Jing Q, Hu Y, Lin C, Zhou R, Wang X, Su Y, Yuan J, Chen Z, Yuan J, Wu J, Li J, Zhu X, Li M.

J Infect. 2015 Jun;70(6):631-40. doi: 10.1016/j.jinf.2014.12.001. Epub 2014 Dec 11.

PMID:
25499200
9.

Interferon lambda inhibits dengue virus replication in epithelial cells.

Palma-Ocampo HK, Flores-Alonso JC, Vallejo-Ruiz V, Reyes-Leyva J, Flores-Mendoza L, Herrera-Camacho I, Rosas-Murrieta NH, Santos-López G.

Virol J. 2015 Sep 28;12:150. doi: 10.1186/s12985-015-0383-4.

10.

A Combined Genetic-Proteomic Approach Identifies Residues within Dengue Virus NS4B Critical for Interaction with NS3 and Viral Replication.

Chatel-Chaix L, Fischl W, Scaturro P, Cortese M, Kallis S, Bartenschlager M, Fischer B, Bartenschlager R.

J Virol. 2015 Jul;89(14):7170-86. doi: 10.1128/JVI.00867-15. Epub 2015 Apr 29.

11.

Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication.

van Cleef KW, Overheul GJ, Thomassen MC, Kaptein SJ, Davidson AD, Jacobs M, Neyts J, van Kuppeveld FJ, van Rij RP.

Antiviral Res. 2013 Aug;99(2):165-71. doi: 10.1016/j.antiviral.2013.05.011. Epub 2013 Jun 2.

PMID:
23735301
12.

Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of dengue virus.

Soto-Acosta R, Bautista-Carbajal P, Syed GH, Siddiqui A, Del Angel RM.

Antiviral Res. 2014 Sep;109:132-40. doi: 10.1016/j.antiviral.2014.07.002. Epub 2014 Jul 11.

PMID:
25017471
13.

The roles of IRF-3 and IRF-7 in innate antiviral immunity against dengue virus.

Chen HW, King K, Tu J, Sanchez M, Luster AD, Shresta S.

J Immunol. 2013 Oct 15;191(8):4194-201. doi: 10.4049/jimmunol.1300799. Epub 2013 Sep 16.

14.

Dengue virus replication in infected human keratinocytes leads to activation of antiviral innate immune responses.

Surasombatpattana P, Hamel R, Patramool S, Luplertlop N, Thomas F, Desprès P, Briant L, Yssel H, Missé D.

Infect Genet Evol. 2011 Oct;11(7):1664-73. doi: 10.1016/j.meegid.2011.06.009. Epub 2011 Jun 21.

PMID:
21722754
15.

SUMO Modification Stabilizes Dengue Virus Nonstructural Protein 5 To Support Virus Replication.

Su CI, Tseng CH, Yu CY, Lai MMC.

J Virol. 2016 Apr 14;90(9):4308-4319. doi: 10.1128/JVI.00223-16. Print 2016 May.

16.

STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor.

Perry ST, Buck MD, Lada SM, Schindler C, Shresta S.

PLoS Pathog. 2011 Feb;7(2):e1001297. doi: 10.1371/journal.ppat.1001297. Epub 2011 Feb 17.

17.

Narasin, a novel antiviral compound that blocks dengue virus protein expression.

Low JS, Wu KX, Chen KC, Ng MM, Chu JJ.

Antivir Ther. 2011;16(8):1203-18. doi: 10.3851/IMP1884.

PMID:
22155902
18.

DEAD-box RNA helicase DDX3X inhibits DENV replication via regulating type one interferon pathway.

Li G, Feng T, Pan W, Shi X, Dai J.

Biochem Biophys Res Commun. 2015 Jan 2;456(1):327-32. doi: 10.1016/j.bbrc.2014.11.080. Epub 2014 Nov 28.

PMID:
25437271
19.

A MicroRNA Screen Identifies the Wnt Signaling Pathway as a Regulator of the Interferon Response during Flavivirus Infection.

Smith JL, Jeng S, McWeeney SK, Hirsch AJ.

J Virol. 2017 Mar 29;91(8). pii: e02388-16. doi: 10.1128/JVI.02388-16. Print 2017 Apr 15.

20.

Susceptibility and initial immune response of Tupaia belangeri cells to dengue virus infection.

Kayesh MEH, Kitab B, Sanada T, Hayasaka D, Morita K, Kohara M, Tsukiyama-Kohara K.

Infect Genet Evol. 2017 Jul;51:203-210. doi: 10.1016/j.meegid.2017.04.003. Epub 2017 Apr 6.

Supplemental Content

Support Center